These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33048622)

  • 1. Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients.
    Clark D; Puri R; Nissen SE
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):873-880. PubMed ID: 33048622
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of statins on serial coronary calcification during atheroma progression and regression.
    Puri R; Nicholls SJ; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2015 Apr; 65(13):1273-1282. PubMed ID: 25835438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease.
    Elshazly MB; Mani P; Nissen S; Brennan DM; Clark D; Martin S; Jones SR; Quispe R; Donnellan E; Nicholls SJ; Puri R
    Eur J Prev Cardiol; 2020 Jul; 27(10):1091-1100. PubMed ID: 31744333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
    Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
    Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.
    Hartmann M; Huisman J; Böse D; Jensen LO; Schoenhagen P; Mintz GS; Erbel R; von Birgelen C
    Eur J Echocardiogr; 2011 Apr; 12(4):313-21. PubMed ID: 21421584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
    Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE
    JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.
    Lee SE; Chang HJ; Sung JM; Park HB; Heo R; Rizvi A; Lin FY; Kumar A; Hadamitzky M; Kim YJ; Conte E; Andreini D; Pontone G; Budoff MJ; Gottlieb I; Lee BK; Chun EJ; Cademartiri F; Maffei E; Marques H; Leipsic JA; Shin S; Choi JH; Chinnaiyan K; Raff G; Virmani R; Samady H; Stone PH; Berman DS; Narula J; Shaw LJ; Bax JJ; Min JK
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1475-1484. PubMed ID: 29909109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-induced coronary artery disease regression rates differ in men and women.
    Puri R; Nissen SE; Nicholls SJ
    Curr Opin Lipidol; 2015 Aug; 26(4):276-81. PubMed ID: 26132419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of coronary atheroma with statin therapy.
    Elshazly MB; Stegman B; Puri R
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):131-7. PubMed ID: 26910274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
    Am J Cardiol; 2013 Apr; 111(7):923-9. PubMed ID: 23337838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
    Am J Cardiol; 2012 May; 109(9):1247-53. PubMed ID: 22325089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving coronary plaque regression: a decades-long battle against coronary artery disease.
    Manubolu VS; Budoff MJ
    Expert Rev Cardiovasc Ther; 2022 Apr; 20(4):291-305. PubMed ID: 35466832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors underlying regression of coronary atheroma with potent statin therapy.
    Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
    J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.
    Stegman B; Shao M; Nicholls SJ; Elshazly M; Cho L; King P; Kapadia S; Tuzcu M; Nissen SE; Puri R
    Atherosclerosis; 2016 Nov; 254():78-84. PubMed ID: 27710808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.